Lumbar Paravertebral Block vs Erector Spinae Plane Block in Elderly Patients Undergoing Lumbar Spine Surgery

ConditionSpine Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-100
SponsorPoznan University of Medical Sciences

About this trial

This prospective, randomized controlled trial aims to compare the analgesic efficacy of lumbar paravertebral block (L-PVB) and lumbar erector spinae plane block (L-ESPB) in elderly patients undergoing lumbar spine surgery. Effective postoperative pain management in this population is essential due to increased susceptibility to opioid-related adverse effects.

Participants aged 65 years and older will be randomly assigned to receive either bilateral L-PVB or bilateral L-ESPB in addition to standardized general anesthesia. The primary objective is to evaluate differences in postoperative opioid consumption within the first 48 hours after surgery. Secondary outcomes include pain intensity, intraoperative opioid use, time to mobilization, length of hospital stay, and incidence of opioid-related adverse events.

Eligibility criteria

Qualifiers

ge ≥65 years

Scheduled for elective lumbar spine surgery

American Society of Anesthesiologists (ASA) physical status I-III

Ability to assess pain using the Numeric Rating Scale (NRS)

Disqualifiers

Refusal to participate

Chronic opioid therapy

Coagulation disorders

Use of anticoagulant therapy contraindicating regional anesthesia

Trial design

Treatments tested in this trial

  • Ropivacaine 0.2% Injectable Solution
  • Ropivacaine 0.2% Injectable Solution

Treatment groups

120 Participants
are divided into 3 treatment groups